Capitolis Advisors LLC Moderna, Inc. Transaction History

Capitolis Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $17.8 Million - $33.1 Million	-140,759 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $7.95 Million - $13 Million	35,196 Added 33.34%	140,759 $35.8 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $20.6 Million - $44.9 Million	92,625 Added 715.91%	105,563 $35.3 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $1.68 Million - $3.04 Million	12,938 New	12,938 $3.04 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.